NCT05685004
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05685004
Title Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors TVAX Biomedical
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Center for Neurosciences Tucson Arizona 85718 United States Details
Cedar-Sanai Medical Center Los Angeles California 90048 United States Details
University of Southern California Keck School of Medicine Los Angeles California 90048 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Aaron Mammoser Atlanta Georgia 30309 United States Details
University of Kansas Medical Center Kansas City Kansas 66061 United States Details
Capital Health Pennington New Jersey 08534 United States Details
Providence St. Vincent Portland Oregon 97225 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field